Laboratory Medicine Consultants, Ltd. Notifies Patients of Data Security Incident

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

LAS VEGAS, July 19, 2019 /PRNewswire/ — Laboratory Medicine Consultants, Ltd. (“LMC”) has been informed by Retrieval Masters Creditors Bureau d/b/a American Medical Collection Agency (“AMCA”) of a data security incident involving the AMCA payment website. AMCA is an independent collection agency that LMC and many other entities used for debt collection. The incident is limited to AMCA’s systems.  The security of LMC’s systems was not affected by this incident.

According to AMCA, on March 21, 2019, AMCA became aware of facts indicating there had been a data security incident. After conducting an investigation, in May of 2019, AMCA notified LMC about the incident and informed LMC that an AMCA database containing information for some LMC patients had been affected. However, at the time of AMCA’s initial notification, AMCA did not provide LMC with enough information for LMC to identify potentially affected patients or confirm the nature of patient information potentially involved in the incident, and LMC’s investigation is on-going. Based on the information provided by AMCA, the following information belonging to LMC patients may have been affected by the incident: patient names, addresses, phone numbers, dates of birth, dates of service, balance information, credit card or banking information and treatment provider information.  AMCA has advised LMC that its patients’ social security numbers were not involved in the incident.  LMC does not provide AMCA healthcare records such as laboratory results and clinical history. 

In response to the breach, AMCA sent notification letters to approximately 4,200 LMC patients informing them that their names, addresses, phone numbers, dates of birth, dates of service, balance information, credit card or banking information and treatment provider information may have been impacted.  In addition, based on the investigation and the information provided by AMCA, LMC estimates that approximately another 143,400 patients may have had their names, addresses, phone numbers, dates of birth, dates of service, balance information and treatment provider information impacted by this incident.  For these patients, credit card and banking information is not affected. The impact of this incident is limited to laboratory services provided to patients in the United States whose accounts were referred for debt collection.

Individuals with questions about this incident or questions about precautionary steps they can take may call 833-300-6928 for additional information.

LMC takes the security of its patients’ information very seriously, including the security of data handled by vendors.  As a result of the investigation, LMC is no longer using AMCA for collection efforts.

The privacy and protection of patient information is a top priority.  LMC greatly appreciates the patience and loyalty of its patients as it works to respond to this incident.

View original content:http://www.prnewswire.com/news-releases/laboratory-medicine-consultants-ltd-notifies-patients-of-data-security-incident-300888273.html

SOURCE Laboratory Medicine Consultants, Ltd.

Staff

Recent Posts

TMCI Deadline: Rosen Law Firm Urges Treace Medical Concepts, Inc. (NASDAQ: TMCI) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors that a…

11 hours ago

Introducing Tempus One in the EHR with Integrated Guidelines

The AI-enabled clinical assistant is available to query patient data across the EHR as well…

14 hours ago

Novartis Kisqali® reduces risk of recurrence in younger patients with early breast cancer in NATALEE subgroup analysis

33% reduction in relative risk of invasive disease observed in pre-menopausal early breast cancer (EBC)…

14 hours ago

Seer’s Proteograph Platform Enables Unprecedented 20,000-Sample Proteomics Study with Korea University to Develop AI-Driven Diagnostics for Cancers in Young Adults

First-of-its-kind study will use Seer’s next-generation workflow to identify early-onset cancer biomarkers and power deep,…

14 hours ago